Thus, our pilot studies, for the first time, showed changes in the TGF-α and PDGF-AA serum levels in schizophrenia patients (especially in female patients) and VEGF in male patients in comparison with healthy persons and an increase in FGF-2 in the long course of the disease. The gene discussed is FGF2; the disease is schizophrenia.